Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Oncogene ; 28(46): 4065-74, 2009 Nov 19.
Article in English | MEDLINE | ID: mdl-19734943

ABSTRACT

In this study, high-throughput microRNA (miRNA) expression analysis revealed that the expression of miR-140 was associated with chemosensitivity in osteosarcoma tumor xenografts. Tumor cells ectopically transfected with miR-140 were more resistant to methotrexate and 5-fluorouracil (5-FU). Overexpression of miR-140 inhibited cell proliferation in both osteosarcoma U-2 OS (wt-p53) and colon cancer HCT 116 (wt-p53) cell lines, but less so in osteosarcoma MG63 (mut-p53) and colon cancer HCT 116 (null-p53) cell lines. miR-140 induced p53 and p21 expression accompanied with G(1) and G(2) phase arrest only in cell lines containing wild type of p53. Histone deacetylase 4 (HDAC4) was confirmed to be one of the important targets of miR-140. The expression of endogenous miR-140 was significantly elevated in CD133(+hi)CD44(+hi) colon cancer stem-like cells that exhibit slow proliferating rate and chemoresistance. Blocking endogenous miR-140 by locked nucleic acid-modified anti-miR partially sensitized resistant colon cancer stem-like cells to 5-FU treatment. Taken together, our findings indicate that miR-140 is involved in the chemoresistance by reduced cell proliferation through G(1) and G(2) phase arrest mediated in part through the suppression of HDAC4. miR-140 may be a candidate target to develop novel therapeutic strategy to overcome drug resistance.


Subject(s)
Bone Neoplasms/genetics , Colonic Neoplasms/genetics , Drug Resistance, Neoplasm/genetics , MicroRNAs/physiology , Osteosarcoma/genetics , Antimetabolites, Antineoplastic/pharmacology , Bone Neoplasms/pathology , Cell Cycle/drug effects , Cell Cycle/genetics , Cell Proliferation/drug effects , Colonic Neoplasms/pathology , Fluorouracil/pharmacology , Gene Expression Regulation, Neoplastic , Genes, p53/physiology , HCT116 Cells , Humans , Methotrexate/pharmacology , MicroRNAs/genetics , Osteosarcoma/pathology , Transfection , Tumor Cells, Cultured , Up-Regulation/genetics , Up-Regulation/physiology
SELECTION OF CITATIONS
SEARCH DETAIL